bluuebunny/crossref_metadata_2025_split huggingface dataset:
THE AMOUNT OF BALLOON FIXATION FLUID VOLUME EFFECTSS ON URINE LEAKAGE IN PERMANENT CATHETER INSTALLATION
Authors: Marwaningsih Veronica Ririn 
Published: March 2021

THE AMOUNT OF BALLOON FIXATION FLUID VOLUME EFFECTSS ON URINE LEAKAGE IN PERMANENT CATHETER INSTALLATION

Ririn Marwaningsih1, Sunarsih2, NikenAstuti 3

1Program studi D III, Sekolah Tinggi Ilmu Kesehatan Elisabeth Semarang
Email : ririn.marwaningsih@yahoo.com
2RS Elisabeth Semarang Email : sunarsihutagalung1@gmail.com

ABSTRACT
Background: The appropriate volume of balloon fixation still becomes a matter of discussion in the permanent catheter installation. The providing of fixation fluid on varied catheter installation is still found practically. The incidence of urine leakage in patients with permanent catheters is still often found. The amount of fixation fluid volume used needs to be studied to provide input on how much the right fixation volume for the permanent catheter installation. The purpose of this study is to determine the role of the amount of catheter balloon fixation volume on the incidence of permanent catheter leakage.
Methods: The design of this research is analytic observational with a cross-sectional approach. The research population was patients in private hospitals in Semarang who had permanent catheters installed. The sample uses total sampling in accordance with the inclusion and exclusion criteria by taking samples from 17-21 January 2019 as many as 53 respondents.
Results: 33 (62.3%) respondents had 10 ml fixation volume permanent catheter (62.3%), 13 respondents (24.5%) had permanent 20 ml balloon fixation volume and 7 (13.2%) respondents had permanent 25 ml balloon fixation volume. There were 7 respondents (13.2%) who had urine leakage and 46 respondents (86.8%) did not. The Mann-Whitney test showed a p value of 0.047 (<0.05).
Conclusion: the volume of balloon fixation fluid has a role in the incidence of urine leakage in permanent catheter installation.
Key words: volume of catheter balloon fixation fluid, catheter balloon, urine leakage, permanent catheter
Comprehensive Analyses of circRNA Expression Profiles and Function Prediction in Chicken Cecums After Eimeria tenella Infection
Authors: Yu Hailiang , Mi Changhao , Wang Qi , Zou Wenbin , Dai Guojun , Zhang Tao , Zhang Genxi , Xie Kaizhou , Wang Jinyu , Shi Huiqiang 
Published: March 2021

Coccidiosis is an important intestinal parasitic disease that causes great economic losses to the global poultry production industry. Circular RNAs (circRNAs) are long non-coding RNAs that play important roles in various infectious diseases and inflammatory responses. However, the expression profiles and functions of circRNAs during Eimeria tenella (E. tenella) infection remain unclear. In this study, high-throughput sequencing was carried out to detect circRNAs in chicken cecal tissues from the control (JC), resistant (JR), and susceptible (JS) groups on day 4.5 postinfection (pi), respectively. A total of 104 circRNAs were differentially expressed, including 47 circRNAs between the JS and JC groups, 38 between the JR and JS groups, and 19 between the JR and JC groups. Functional analyses indicated that these differentially expressed circRNAs were involved in pathways related to E. tenella infection; the adaptive immune response was enriched in the JS vs JC group, the NF-kappa B signaling and natural killer cell-mediated cytotoxicity pathways were enriched in the JS vs JC and JR vs JC groups, while the B cell receptor signaling pathway was enriched in only the JR vs JC group. Moreover, the coexpression network of differentially expressed circRNAs and mRNAs suggested that circRNA2202 and circRNA0759 associated with DTX1 in the JS vs JC group, circRNA4338 associated with VPREB3 and CXCL13L3 in the JR vs JC group, and circRNA2612 associated with IL8L1 and F2RL2 in the JR vs JS group were involved in the immune response upon E. tenella infection. In conclusion, our results provide valuable information on the circRNAs involved in the progression of chicken E. tenella infection and advance our understanding of the circRNA regulatory mechanisms of host resistance and susceptibility to E. tenella infection in chickens.
Impacts of Indian Ocean Dipole–Like SST on Rice Yield Anomalies in Jiangsu Province
Authors: Xu Jingwei , Koldunov Nikolay V. , Xu Min , Zhu Xiuhua , Fraedrich Klaus , Jiang Xi , Zhu Shoupeng , Zhi Xiefei 
Published: March 2021

One of the main water vapor sources of eastern China is the Bay of Bengal, over which the circulation is influenced by the Tropical Indian Ocean Dipole (TIOD). The TIOD has a long-lasting effect on weather patterns, which in turn influence the rice yield and quality in eastern China, such as in Jiangsu Province. To identify the main mechanism involved, we perform a detailed investigation of the connections between the TIOD-like sea surface temperature (SST) and the climatic suitability for growing rice, and the subsequent rice yield anomalies, in Jiangsu Province. In particular, we compare the relationships, and identify the underlying mechanisms, of TIOD SST with suitable sunshine duration, temperature and precipitation during the period of rice culture in the province. Singular Value Decomposition (SVD) results show that the TIOD-like SST has a close correlation with the rice yield anomalies, with a temporal correlation coefficient of 0.43 for 53 years, passing the 99% significance level. Furthermore, in the negative TIOD-like SST years, the background circulation weakens the transport effect of the atmospheric river through which water vapor is transported from the Bay of Bengal to eastern China. This decreased amount of transported water vapor decreases the precipitation and total cloud cover in the province. In turn, this significantly increases the sunshine duration, which plays a key role in rice yield anomalies. The increased sunshine duration and higher temperatures lead to positive rice yield anomalies, and vice versa. Our findings highlight that climatic factors, such as TIOD-like SST, have a far-reaching influence on agricultural production (in this case, rice yield), and thus special attention should be paid to interdisciplinary research in the fields of climate and agriculture.
Insulin Therapy in Type 2 Diabetes Is Associated With Barriers to Activity and Worse Health Status: A Cross-Sectional Study in Primary Care
Authors: Boels Anne Meike , Rutten Guy , Cleveringa Frits , van Avendonk Mariëlle , Vos Rimke 
Published: March 2021

IntroductionMany individuals with type 2 diabetes mellitus (T2DM) experience “psychological insulin resistance”. Consequently, it could be expected that insulin therapy may have negative effects on psychological outcomes and well-being. Therefore, this study compared health status and psychosocial functioning of individuals with T2DM using only oral antihyperglycemic agents (OHA) and on insulin therapy (with or without OHA).Materials and MethodsIn this cross-sectional study, we used baseline data of a cluster randomized controlled trial conducted in 55 Dutch general practices in 2005. Health status was measured with the Short Form (SF)-36 (scale 0–100) and psychosocial functioning with the Diabetes Health Profile (DHP, scale 0-100). To handle missing data, we performed multiple imputation. We used linear mixed models with random intercepts per general practice to correct for clustering at practice level and to control for confounding.ResultsIn total, 2,794 participants were included in the analysis, their mean age was 65.8 years and 50.8% were women. Insulin-users (n = 212) had a longer duration of T2DM (11.0 versus 5.6 years) and more complications. After correcting for confounders and multiple comparisons, insulin-users reported significantly worse outcomes on vitality (SF-36, adjusted difference -5.7, p=0.033), general health (SF-36, adjusted difference -4.8, p=0.043), barriers to activity (DHP, adjusted difference -7.2, p&lt;0.001), and psychological distress (DHP, adjusted difference -3.7, p=0.004), all on a 0-100 scale.DiscussionWhile previous studies showed similar or better health status in people with type 2 diabetes receiving insulin therapy, we found that vitality, general health and barriers to activity were worse in those on insulin therapy. Although the causality of this association cannot be established, our findings add to the discussion on the effects of insulin treatment on patient-reported outcomes in daily practice.
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
Authors: Tumminia Andrea , Scalisi Nunzio M. , Milluzzo Agostino , Ettore Giuseppe , Vigneri Riccardo , Sciacca Laura 
Published: March 2021

BackgroundMaternal high blood glucose during pregnancy increases the risk for both maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of hyperglycemia on placental development and growth have not been fully illustrated yet. The placenta expresses high amounts of both insulin receptor (IR) and insulin-like growth factor receptor (IGF-1R). It has been reported that the placenta of diabetic women has structural and functional alterations and the insulin/IGF system is likely to play a role in these changes. The aim of the present study was to measure the content of IR and IGF-1R and their phosphorylation in the placenta of women with type 1 diabetes mellitus (T1D) or with gestational diabetes mellitus (GDM) compared to women with normal glucose tolerance (NGT) during pregnancy.MethodsPlacental tissues were obtained from 80 Caucasian women with a singleton pregnancy. In particular, we collected placenta samples from 20 T1D patients, 20 GDM patients and 40 NGT women during pregnancy. Clinical characteristics and anthropometric measures of all women as well as delivery and newborn characteristics were recorded. Patients were also subdivided on the basis of peripartum glycemia either ≥90 mg/dl or &lt;90 mg/dl, regardless of the diagnosis.ResultsIn T1D patients, a higher rate of adverse outcomes was observed. Compared to the GDM women, the T1D group showed significantly higher average capillary blood glucose levels at the third trimester of pregnancy and at peripartum, and higher third-trimester HbA1c values. In both T1D and GDM women, HbA1c values during pregnancy correlated with glucose values in the peripartum period (R-squared 0.14, p=0.02). A positive correlation was observed between phosphorylation of placental IR and the glucose levels during the third trimester of GDM and T1D pregnancy (R-squared 0.21, p=0.003). In the placenta of T1D patients, IGF-1R phosphorylation and IR isoform A (IR-A) expression were significantly increased (p=0.006 and p=0.040, respectively), compared to the NGT women. Moreover, IGF-1R phosphorylation was significantly increased (p&lt;0.0001) in the placenta of patients with peripartum glucose &gt;90 mg/dl, while IR-A expression was increased in those with peripartum blood glucose higher than 120 mg/dl (p=0.046).ConclusionsTo the best of our knowledge, our study represents the first one in which an increased maternal blood glucose level during pregnancy is associated with an increased IGF-1R phosphorylation and IR-A expression in the placenta. Both these mechanisms can promote an excessive fetal growth.
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
Authors: Cinetto Francesco , Scarpa Riccardo , Carrabba Maria , Firinu Davide , Lougaris Vassilios , Buso Helena , Garzi Giulia , Gianese Sabrina , Soccodato Valentina , Punziano Alessandra , Lagnese Gianluca , Tessarin Giulio , Costanzo Giulia , Landini Nicholas , Vio Stefania , Bondioni Maria Pia , Consonni Dario , Marasco Carolina , Del Giacco Stefano , Rattazzi Marcello , Vacca Angelo , Plebani Alessandro , Fabio Giovanna , Spadaro Giuseppe , Agostini Carlo , Quinti Isabella , Milito Cinzia 
Published: March 2021

Background: Granulomatous and Lymphocytic Interstitial Lung Diseases (GLILD) is a severe non-infectious complication of Common Variable Immunodeficiency (CVID), often associated with extrapulmonary involvement. Due to a poorly understood pathogenesis, GLILD diagnosis and management criteria still lack consensus. Accordingly, it is a relevant cause of long-term loss of respiratory function and is closely associated with a markedly reduced survival. The aim of this study was to describe clinical, immunological, laboratory and functional features of GLILD, whose combination in a predictive model might allow a timely diagnosis.Methods: In a multicenter retrospective cross-sectional study we enrolled 73 CVID patients with radiologic features of interstitial lung disease (ILD) associated to CVID (CVID-ILD) and 125 CVID patients without ILD (controls). Of the 73 CVID-ILD patients, 47 received a definite GLILD diagnosis while 26 received a clinical-radiologic diagnosis of CVID related ILD defined as uILD.Results: In GLILD group we found a higher prevalence of splenomegaly (84.8 vs. 39.2%), autoimmune cytopenia (59.6 vs. 6.4%) and bronchiectasis (72.3 vs. 28%), and lower IgA and IgG serum levels at CVID diagnosis. GLILD patients presented lower percentage of switched-memory B cells and marginal zone B cells, and a marked increase in the percentage of circulating CD21lo B cells (14.2 vs. 2.9%). GLILD patients also showed lower total lung capacity (TLC 87.5 vs. 5.0%) and gas transfer (DLCO 61.5 vs. 5.0%) percent of predicted. By univariate logistic regression analysis, we found IgG and IgA levels at CVID diagnosis, presence of splenomegaly and autoimmune cytopenia, CD21lo B cells percentage, TLC and DCLO percent of predicted to be associated to GLILD. The joint analysis of four variables (CD21lo B cells percentage, autoimmune cytopenia, splenomegaly and DLCO percent of predicted), together in a multiple logistic regression model, yielded an area under the ROC curve (AUC) of 0.98 (95% CI: 0.95-1.0). The AUC was only slightly modified when pooling together GLILD and uILD patients (0.92, 95% CI: 0.87-0.97).Conclusions: we propose the combination of two clinical parameters (splenomegaly and autoimmune cytopenia), one lung function index (DLCO%) and one immunologic variable (CD21lo%) as a promising tool for early identification of CVID patients with interstitial lung disease, limiting the use of aggressive diagnostic procedures.
Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China
Authors: Zhu Wei , Zhang Huaqiu , Li Yong , Ding Zeyang , Liu Zhuo , Ruan Yajun , Feng Huan , Li Ganxun , Liu Bo , He Fan , Zhou Ning , Jiang Jiangang , Wen Zhixiang , Xu Gang , Zhao Jianping , Zhang Bixiang , Wang Daowen , Tang Zhouping , Wang Hui , Liu Jihong 
Published: March 2021

Background: The coronavirus disease 2019 (COVID-19) has swept through the world at a tremendous speed, and there is still limited data available on the treatment for COVID-19. The mortality of severely and critically ill COVID-19 patients in the Optical Valley Branch of Tongji Hospital was low. We aimed to analyze the available treatment strategies to reduce mortality.Methods: In this retrospective, single-center study, we included 1,106 COVID-19 patients admitted to the Optical Valley Branch of Tongji Hospital from February 9 to March 9, 2020. Cases were analyzed for demographic and clinical features, laboratory data, and treatment methods. Outcomes were followed up until March 29, 2020.Results: Inflammation-related indices (hs-CRP, ESR, serum ferritin, and procalcitonin) were significantly higher in severe and critically ill patients than those in moderate patients. The levels of cytokines, including IL-6, IL2R, IL-8, and TNF-α, were also higher in the critical patients. Incidence of acute respiratory distress syndrome (ARDS) in the severely and critically ill group was 23.0% (99/431). Sixty-one patients underwent invasive mechanical ventilation. The correlation between SpO2/FiO2 and PaO2/FiO2 was confirmed, and the cut-off value of SpO2/FiO2 related to survival was 134.43. The mortality of patients with low SpO2/FiO2 (&lt;134.43) at intubation was higher than that of patients with high SpO2/FiO2 (&gt;134.43) (72.7 vs. 33.3%). Among critical patients, the application rates of glucocorticoid therapy, continuous renal replacement therapy (CRRT), and anticoagulation treatment reached 55.2% (238/431), 7.2% (31/431), and 37.1% (160/431), respectively. Among the intubated patients, the application rates of glucocorticoid therapy, CRRT, and anticoagulation treatment were respectively 77.0% (47/61), 54.1% (33/61), and 98.4% (60/61).Conclusion: No vaccines or specific antiviral drugs for COVID-19 have been shown to be sufficiently safe and effective to date. Comprehensive treatment including ventilatory support, multiple organ function preservation, glucocorticoid use, renal replacement therapy, anticoagulation, and restrictive fluid management was the main treatment strategy. Early recognition and intervention, multidisciplinary collaboration, multi-organ function support, and personalized treatment might be the key for reducing mortality.
Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins
Authors: Wang Wei , Chen Ning-yuan , Ren Dewei , Davies Jonathan , Philip Kemly , Eltzschig Holger K. , Blackburn Michael R. , Akkanti Bindu , Karmouty-Quintana Harry , Weng Tingting 
Published: March 2021

Background: Acute respiratory distress syndrome (ARDS) is a clinical presentation of acute lung injury (ALI) with often fatal lung complication. Adenosine, a nucleoside generated following cellular stress provides protective effects in acute injury. The levels of extracellular adenosine can be depleted by equilibrative nucleoside transporters (ENTs). ENT inhibition by pharmaceutical agent dipyridamole promotes extracellular adenosine accumulation and is protective in ARDS. However, the therapeutic potential of dipyridamole in acute lung injury has not yet been evaluated.Methods: Adenosine acts on three adenosine receptors, the adenosine A1 (Adora1), A2a (Adora2a), the A2b (Adora2b) or the adenosine A3 (Adora 3) receptor. Accumulation of adenosine is usually required to stimulate the low-affinity Adora2b receptor. In order to investigate the effect of adenosine accumulation and the contribution of epithelial-specific ENT2 or adora2b expression in experimental ALI, dipyridamole, and epithelial specific ENT2 or Adora2b deficient mice were utilized. MLE12 cells were used to probe downstream Adora2b signaling. Adenosine receptors, transporters, and targets were determined in ARDS lungs.Results: ENT2 is mainly expressed in alveolar epithelial cells and is negatively regulated by hypoxia following tissue injury. Enhancing adenosine levels with ENT1/ENT2 inhibitor dipyridamole at a time when bleomycin-induced ALI was present, reduced further injury. Mice pretreated with the ADORA2B agonist BAY 60-6583 were protected from bleomycin-induced ALI by reducing vascular leakage (558.6 ± 50.4 vs. 379.9 ± 70.4, p &lt; 0.05), total bronchoalveolar lavage fluid cell numbers (17.9 ± 1.8 to 13.4 ± 1.4 e4, p &lt; 0.05), and neutrophil infiltration (6.42 ± 0.25 vs. 3.94 ± 0.29, p &lt; 0.05). While mice lacking Adora2b in AECs were no longer protected by dipyridamole. We also identified occludin and focal adhesion kinase as downstream targets of ADORA2B, thus providing a novel mechanism for adenosine-mediated barrier protection. Similarly, we also observed similar enhanced ADORA2B (3.33 ± 0.67 to 16.12 ± 5.89, p &lt; 0.05) and decreased occludin (81.2 ± 0.3 to 13.3 ± 0.4, p &lt; 0.05) levels in human Acute respiratory distress syndrome lungs.Conclusion: We have highlighted a role of dipyridamole and adenosine signaling in preventing or treating ALI and identified Ent2 and Adora2b as key mediators in important for the resolution of ALI.
BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors
Authors: Dudnik Elizabeth , Bar Jair , Moore Assaf , Gottfried Teodor , Moskovitz Mor , Dudnik Julia , Shochat Tzippy , Allen Aaron M. , Zer Alona , Rotem Ofer , Peled Nir , Urban Damien 
Published: March 2021

ObjectivesLittle is known regarding the outcomes of systemic treatments in BAP1-altered malignant pleural mesothelioma (MPM).Materials and MethodsForty five patients with MPM [group A: eight MPM patients with BAP1 inactivating mutation/copy number loss (FoundationOne® CDx/TEMPUSxT), selected from the electronic databases of four Israeli cancer centers (ICC); group B: 37 consecutive (years 2016–2018) MPM patients selected from the electronic databases of two ICC—of those six patients without a BAP1 alteration (group B1) and 31 patients not tested for BAP1 (group B2)] were analyzed for ORR, PFS (mRECIST), and OS with 1st-line platinum/pemetrexed+/−antiangiogenic drug (CT, n-28), immune check-point inhibitors (ICPi, n-16) and poly (ADP-ribose) polymerase inhibitors (PARPi, n-4). OS since diagnosis (OSDx) was assessed.ResultsThere were no differences in ORR or mPFS with CT between the groups: ORR-50% vs. 47% vs. 50% vs. 47% (p&gt;0.9), mPFS-9.1mo (95% CI, 1.2–16.1) vs. 9.2mo (95% CI, 2.9–13.3) vs. 7.2mo (95% CI, 2.3-NR) vs. 10.9mo (95% CI, 2.9–20.3) (p&gt;0.8) in groups A, B, B1, and B2, respectively. There were no differences in ORR or mPFS with ICPi between the groups: ORR-0% vs. 27% vs. 33% vs. 25% (p&gt;0.2), mPFS-2.5mo (95% CI, 1.4–3.7) vs. 3.0mo (95% CI, 1.3–10.5) vs. 2.0mo (95% CI, 1.9-NR) vs. 4.5mo (95% CI, 0.3–10.5) (p&gt;0.3) in groups A, B, B1, and B2, respectively. In group A, no responses were seen with PARPi; mPFS with PARPi was 1.8mo (95% CI, 1.8-NR). OSDx was 98.3mo (95% CI, 9.7–98.3) vs. 19.4mo (95% CI, 9.7–47.3) vs. 18.8mo (95% CI, 8.5-NR) vs. 19.5mo (95% CI, 8.3–82.2) in groups A, B, B1, and B2, respectively (p&gt;0.3).ConclusionsBAP1-altered MPM, as compared to non-selected MPM, is characterized by similar efficacy of CT and ICPi. Numerically longer OS in BAP1-altered MPM may reflect favorable tumor biology. No responses were observed with PARPi.